hydralazine has been researched along with tak 044 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kano, H; Kohno, M; Minami, M; Tatsumi, Y; Ueda, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
1 other study(ies) available for hydralazine and tak 044
Article | Year |
---|---|
Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Hydralazine; Hypertension, Malignant; Kidney; Male; Myocardium; Organ Size; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Reference Values; Sodium Chloride | 1997 |